Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 4—April 2025
Research

Neutralizing Antibodies against California Serogroup Orthobunyaviruses in Human Serum Samples, Montana, USA

Tyson A. Woods1, Stephen F. Johnson1, Alyssa B. Evans2, and Karin E. PetersonComments to Author 
Author affiliation: Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA

Main Article

Figure 6

Percentage of positive samples from the east region in a study of neutralizing antibodies against California serogroup orthobunyaviruses in human serum samples, Montana, USA. A) Relative percentage of 100 samples with neutralizing antibodies (Table 3); B) percentage of each virus detected at >1:50 dilution in 43 samples. CEV, California encephalitis virus; CVV, Cache Valley virus; JCV, James Canyon virus; LACV, La Crosse virus; TVTV, Trivittatus virus.

Figure 6. Percentage of positive samples from the east region in a study of neutralizing antibodies against California serogroup orthobunyaviruses in human serum samples, Montana, USA. A) Relative percentage of 100 samples with neutralizing antibodies (Table 3); B) percentage of each virus detected at >1:50 dilution in 43 samples. CEV, California encephalitis virus; CVV, Cache Valley virus; JCV, James Canyon virus; LACV, La Crosse virus; TVTV, Trivittatus virus.

Main Article

1These first authors contributed equally to this article.

2Current affiliation: Department of Microbiology and Cell Biology, Montana State University, Bozeman, Montana, USA

Page created: February 08, 2025
Page updated: March 10, 2025
Page reviewed: March 10, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external